All individuals between the ages of 2 years and 99 with an established diagnosis of Niemann-Pick Disease Type C biochemical or molecular will be considered for this study Patients with both Niemann-Pick Disease Type C1 NPC1 and Niemann-Pick Disease Type C2 NPC2 mutations are eligible to participate 